Experiment 374471
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Aesculus hippocastanum (HIPPOCASTANACEAE) |
| Citation | MASUHR,TH: HOLSCHER,U: HONOLD,E:. (1994). BENEFIT-RISK EVALUATION OF VENOPLANT RETARD, A PRODUCT STANDARDIZED ON AESCIN AND BASED ON THE EXTRACT OF HORSE CHESTNUT SEED, IN PATIENTS SUFFERING FROM CHRONIC VENOUS INSUFFICIENCY.. 8() |
| Amount utilized | |
| Compound isolated | |
| Disease | A MULTICENTER SURVEILLANCE STUDY IN 4113 PATIENTS SUFFERING FROM CHRONIC VENOUS INSUFFICIENCY DISEASE WAS TREATED BY SMYPTOMATIC-ORIENTED THERAPY USING A STANDARDIZED HORSE CHESTNUT SEED EXTRACT THERAPY WAS ASSESSED AS VERY GOOD OR GOOD BY 4010 PATIENTS. |
| Dose amount | 200.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | GIVEN TO BOTH SEXES |